NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

GIMV NV (BR: GIMB)

 
GIMB Technical Analysis
4
As on 14th Jan 2026 GIMB STOCK Price closed @ 45.05 and we RECOMMEND Buy for LONG-TERM with Stoploss of 41.52 & Strong Buy for SHORT-TERM with Stoploss of 38.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GIMBSTOCK Price

Open 45.40 Change Price %
High 45.50 1 Day -0.20 -0.44
Low 44.65 1 Week 0.35 0.78
Close 45.05 1 Month -0.15 -0.33
Volume 20141 1 Year 5.05 12.62
52 Week High 47.50 | 52 Week Low 35.25
 
BR Belgium Most Active Stocks
SCHD 27.64 7.51%
ABI 58.96 2.75%
OPTI 0.01 %
BOTHE 0.29 70.59%
ACCB 0.03 %
ACPH 0.89 0.00%
UMI 19.39 -1.02%
WDP 23.26 0.69%
PROX 7.25 3.42%
AGS 59.40 0.51%
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
SCHD 27.64 7.51%
CYAD 0.18 5.88%
CYAD 0.18 5.88%
IBAB 14.16 3.96%
PROX 7.25 3.42%
ANT 6.41 3.22%
ANT 6.41 3.22%
ABI 58.96 2.75%
ABI 58.96 2.75%
 
BR Belgium Top Losers Stocks
BELR 1.93 -74.27%
BELR 1.93 -74.27%
SPA 250.00 -7.41%
SPA 250.00 -7.41%
SPA 250.00 -7.41%
SPA 250.00 -7.41%
SPA 250.00 -7.41%
SPA 250.00 -7.41%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
 
 
GIMB
Daily Charts
GIMB
Intraday Charts
Whats New @
Bazaartrend
GIMB
Free Analysis
 
GIMB Important Levels Intraday
RESISTANCE46.69
RESISTANCE46.16
RESISTANCE45.84
RESISTANCE45.51
SUPPORT44.59
SUPPORT44.26
SUPPORT43.94
SUPPORT43.41
 
GIMB Forecast January 2026
4th UP Forecast54.49
3rd UP Forecast51.46
2nd UP Forecast49.59
1st UP Forecast47.72
1st DOWN Forecast42.38
2nd DOWN Forecast40.51
3rd DOWN Forecast38.64
4th DOWN Forecast35.61
 
GIMB Weekly Forecast
4th UP Forecast47.94
3rd UP Forecast47.01
2nd UP Forecast46.44
1st UP Forecast45.87
1st DOWN Forecast44.23
2nd DOWN Forecast43.66
3rd DOWN Forecast43.09
4th DOWN Forecast42.16
 
GIMB Forecast2026
4th UP Forecast71.35
3rd UP Forecast62.92
2nd UP Forecast57.7
1st UP Forecast52.49
1st DOWN Forecast37.61
2nd DOWN Forecast32.4
3rd DOWN Forecast27.18
4th DOWN Forecast18.75
 
 
GIMB Other Details
Segment EQ
Market Capital 1485089024.00
Sector Financial Services
Industry Asset Management
Offical website >
 
GIMB Address
GIMB
 
GIMB Latest News
 
Your Comments and Response on GIMV NV
 
GIMB Business Profile
GIMV NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to ?125 million ($144.76 million). It seeks to invest between ?3 million ($3.47 million) to ?30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as me Address: Karel Oomsstraat 37, Antwerp, Belgium, 2018
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service